Latest Minimed Paradigm Stories
The world's first clinical trial comparing three alternative treatments for type 1 diabetes was conducted in Montréal by researchers at the IRCM and the University of Montreal, led by endocrinologist Dr. Rémi Rabasa-Lhoret.
SAN DIEGO, Nov. 12, 2014 /PRNewswire/ -- Tandem Diabetes Care®, Inc.
9 major insurance companies in Canada approved the reimbursement of the Montméd Timesulin under "standard group policies that include coverage for diabetic supplies". MONTREAL,
Company's Network and Technology Enable Trial of Artificial Pancreas in California NEW YORK, Aug.
Insulin pumps are significantly more effective at controlling blood glucose (sugar) in people with type 2 diabetes who have failed to respond to the usual standard of care, multiple daily insulin injections.
DUBLIN, May 22, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/wqkgq3/continuous)
ALBANY, New York, May 8, 2014 /PRNewswire/ -- MRRBIZ includes new market research report "Continuous Glucose Monitoring Market (Guardian Real Time, FreeStyle Navigator,
Avail is conducting a 6-week, Phase 2 randomized study to assess the safety, tolerability and pharmacodynamics of a new combination therapy administered to
DUBLIN, April 2, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/ch672j/continuous) has announced the addition of the "Continuous
- A political dynamiter.